AAAAAA
Results:
1-14
|
Results: 14
Authors:
Bon, GG
Kenemans, P
Verstraeten, AA
Go, S
Philipi, PA
van Kamp, GJ
van Geijn, HP
van Vugt, JMG
Citation: Gg. Bon et al., Maternal serum CA125 and CA15-3 antigen levels in normal and pathological pregnancy, FETAL DIAGN, 16(3), 2001, pp. 166-172
Authors:
Stieber, P
Molina, R
Chan, DW
Fritsche, HA
Beyrau, R
Bonfrer, JMG
Filella, X
Gornet, TG
Hoff, T
Jager, W
van Kamp, GJ
Nagel, D
Peisker, K
Sokoll, LJ
Troalen, F
Untch, M
Domke, I
Citation: P. Stieber et al., Evaluation of the analytical and clinical performance of the Elecsys (R) CA 15-3 immunoassay, CLIN CHEM, 47(12), 2001, pp. 2162-2164
Authors:
de Jong, CLD
Paarlberg, KM
van Geijn, HP
van Kamp, GJ
van Dis, H
Dekker, GA
Citation: Cld. De Jong et al., Maternal thromboxane and prostacyclin levels in relation to fetal birth weight, EUR J OB GY, 93(1), 2000, pp. 65-69
Authors:
Colnot, DR
Quak, JJ
Roos, JC
van Lingen, A
Wilhelm, AJ
van Kamp, GJ
Huijgens, PC
Snow, GB
van Dongen, GAMS
Citation: Dr. Colnot et al., Phase I therapy study of Re-186-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck, J NUCL MED, 41(12), 2000, pp. 1999-2010
Authors:
Dik, MG
Jonker, C
Bouter, LM
Geerlings, MI
van Kamp, GJ
Deeg, DJH
Citation: Mg. Dik et al., APOE-epsilon 4 is associated with memory decline in cognitively impaired elderly, NEUROLOGY, 54(7), 2000, pp. 1492-1497
Authors:
Polderman, KH
Stehouwer, CDA
van Kamp, GJ
Schalkwijk, CG
Gooren, LJG
Citation: Kh. Polderman et al., Modulation of plasma endothelin levels by the menstrual cycle, METABOLISM, 49(5), 2000, pp. 648-650
Authors:
von Mensdorff-Pouilly, S
Petrakou, E
Kenemans, P
van Uffelen, K
Verstraeten, AA
Snijdewint, FGM
van Kamp, GJ
Schol, DJ
Reis, CA
Price, MR
Livingston, PO
Hilgers, J
Citation: S. Von Mensdorff-pouilly et al., Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1peptides and N-acetylgalactosamine (GalNAc) peptides, INT J CANC, 86(5), 2000, pp. 702-712
Authors:
Mulder, C
Scheltens, P
Visser, JJ
van Kamp, GJ
Schutgens, RBH
Citation: C. Mulder et al., Genetic and biochemical markers for Alzheimer's disease: recent developments, ANN CLIN BI, 37, 2000, pp. 593-607
Authors:
Dallmeijer, AJ
van der Woude, LHV
van Kamp, GJ
Hollander, AP
Citation: Aj. Dallmeijer et al., Changes in lipid, lipoprotein and apolipoprotein profiles in persons with spinal cord injuries during the first 2 years post-injury, SPINAL CORD, 37(2), 1999, pp. 96-102
Authors:
Verheijen, RHM
von Mensdorff-Pouilly, S
van Kamp, GJ
Kenemans, P
Citation: Rhm. Verheijen et al., CA 125: fundamental and clinical aspects, SEM CANC B, 9(2), 1999, pp. 117-124
Authors:
Bon, GG
van Kamp, GJ
Verstraeten, RA
von Mensdorff-Pouilly, S
Hilgers, J
Kenemans, P
Citation: Gg. Bon et al., Quantification of MUC1 in breast cancer patients - A method comparison study, EUR J OB GY, 83(1), 1999, pp. 67-75
Authors:
Bon, GG
Kenemans, P
Dekker, JJ
Hompes, PG
Verstraeten, RA
van Kamp, GJ
Schoemaker, J
Citation: Gg. Bon et al., Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneousovulatory cycles, HUM REPR, 14(2), 1999, pp. 566-570
Authors:
Mul, D
Schouten-van Meeteren, AYN
van Kamp, GJ
Tan, KEWP
Citation: D. Mul et al., Tumor markers in retinoblastoma, MED PED ONC, 32(2), 1999, pp. 146-147
Authors:
Paarlberg, KM
de Jong, CLD
van Geijn, HP
van Kamp, GJ
Heinen, AGJJ
Dekker, GA
Citation: Km. Paarlberg et al., Vasoactive mediators in pregnancy-induced hypertensive disorders: A longitudinal study, AM J OBST G, 179(6), 1998, pp. 1559-1564
Risultati:
1-14
|